These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 2564279)

  • 1. Assessment of Vecuronium Quality Using Near-Infrared Spectrometry.
    Isaacs JT; Almeter PJ; Hunter AN; Lyman TA; Zapata SP; Henderson BS; Larkin SA; Long LM; Bossle MN; Bhaktawara SA; Warren MF; Lozier AM; Melson JD; Fraley SR; Relucio EHL; Felix MA; Reynolds JW; Naseman RW; Platt TL; Lodder RA
    Contact Context; 2023; 2023():. PubMed ID: 38187821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of action of supplemental doses of vecuronium is related to the duration after the initial dose.
    Otagiri T; Narita M; Nishizawa M; Nishimura C
    J Anesth; 1992 Apr; 6(2):138-44. PubMed ID: 15278557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of pipecuronium in infants, children and adults.
    Tassonyi E; Pittet JF; Schopfer CN; Rouge JC; Gemperle G; Wilder-Smith OH; Morel DR
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):203-8. PubMed ID: 8751042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous vecuronium infusion for prolonged muscle relaxation in children.
    Fitzpatrick KT; Black GW; Crean PM; Mirakhur RK
    Can J Anaesth; 1991 Mar; 38(2):169-74. PubMed ID: 1673644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical uses and controversies of neuromuscular blocking agents in infants and children.
    Martin LD; Bratton SL; O'Rourke PP
    Crit Care Med; 1999 Jul; 27(7):1358-68. PubMed ID: 10446832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vecuronium infusion requirements in pediatric patients during fentanyl-N2O-O2 anesthesia.
    Meretoja OA
    Anesth Analg; 1989 Jan; 68(1):20-4. PubMed ID: 2562909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia.
    Meretoja OA; Wirtavuori K; Neuvonen PJ
    Anesth Analg; 1988 Jan; 67(1):21-6. PubMed ID: 2892436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of epidural bupivacaine on vecuronium-induced neuromuscular blockade in children.
    Taivainen T; Meretoja OA; Rosenberg PH
    Acta Anaesthesiol Scand; 1994 Jul; 38(5):453-6. PubMed ID: 7941939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of action of vecuronium in infants and children anaesthetized without potent inhalation agents.
    Kalli I; Meretoja OA
    Acta Anaesthesiol Scand; 1989 Jan; 33(1):29-33. PubMed ID: 2563621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset and duration of neuromuscular blockade following high-dose vecuronium administration.
    Ginsberg B; Glass PS; Quill T; Shafron D; Ossey KD
    Anesthesiology; 1989 Aug; 71(2):201-5. PubMed ID: 2569279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants?
    Meretoja OA
    Br J Anaesth; 1989 Feb; 62(2):184-7. PubMed ID: 2564279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular transmission and its blockade. Pharmacology, monitoring and physiology updated.
    Jones RM
    Anaesthesia; 1985 Oct; 40(10):964-76. PubMed ID: 2415017
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.